A Structural and Energetic Model for the Slow-Onset
Inhibition of the Mycobacterium tuberculosis Enoyl-ACP
Reductase InhA

A Structural and Energetic Model for the Slow-Onset Inhibition of the Mycobacterium tuberculosis Enoyl-ACP Reductase InhA

Bibliographic Details
Main Authors:	Li, Huei-Jiun, Lai, Cheng-Tsung, Pan, Pan, Yu, Weixuan, Liu, Nina, Bommineni, Gopal R., Garcia-Diaz, Miguel, Simmerling, Carlos, Tonge, Peter J.
Format:	Online
Language:	English
Published:	American Chemical Society 2014
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4004265/

Similar Items

Identification of potential inhibitor targeting enoyl-acyl carrier protein reductase (InhA) in Mycobacterium tuberculosis: a computational approach
by: Shanthi, V., et al.
Published: (2013)

Novel Compounds Targeting InhA for TB Therapy
by: Almatar, Manaf, et al.
Published: (2018)

Slow-Onset Inhibition of Mycobacterium tuberculosis InhA: Revealing Molecular Determinants of Residence Time by MD Simulations
by: Merget, Benjamin, et al.
Published: (2015)

Discovery of azetidine based ene-amides as potent bacterial enoyl ACP reductase (FabI) inhibitors
by: Takhi, M., et al.
Published: (2017)

Discovery of azetidine based ene-amides as potent bacterial enoyl ACP reductase (FabI) inhibitors
by: Takhi, M., et al.
Published: (2018)

Determination of the Crystal Structure and Active Residues of FabV, the Enoyl-ACP Reductase from Xanthomonas oryzae
by: Li, He, et al.
Published: (2011)

Pharmacophore and Molecular Docking Guided 3D-QSAR Study of Bacterial Enoyl-ACP Reductase (FabI) Inhibitors
by: Lu, Xiaoyun, et al.
Published: (2012)

QSAR and Molecular Docking Studies of Oxadiazole-Ligated Pyrrole Derivatives as Enoyl-ACP (CoA) Reductase Inhibitors
by: Asgaonkar, Kalyani D., et al.
Published: (2014)

Effect of the explicit flexibility of the InhA enzyme from Mycobacterium tuberculosis in molecular docking simulations
by: Cohen, Elisangela ML, et al.
Published: (2011)

Molecular Dynamics Assisted Mechanistic Study of Isoniazid-Resistance against Mycobacterium tuberculosis InhA
by: Kumar, Vivek, et al.
Published: (2015)

Minor Contribution of inhA-15 Mutations to the Rapid Detection of Isoniazid Resistance in Mycobacterium Tuberculosis Isolates
by: Abkar, Roya, et al.
Published: (2016)

Bacillus anthracis Protease InhA Increases Blood-Brain Barrier Permeability and Contributes to Cerebral Hemorrhages
by: Mukherjee, Dhritiman V., et al.
Published: (2011)

A selective method for optimizing ensemble docking-based experiments on an InhA Fully-Flexible receptor model
by: Renata De Paris, et al.
Published: (2018-06-01)

High Prevalence of inhA Promoter Mutations among Patients with Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa.
by: Abraham J Niehaus, et al.

An Effective Approach for Clustering InhA Molecular Dynamics Trajectory Using Substrate-Binding Cavity Features
by: De Paris, Renata, et al.
Published: (2015)

High Prevalence of inhA Promoter Mutations among Patients with Drug-Resistant Tuberculosis in KwaZulu-Natal, South Africa
by: Niehaus, Abraham J., et al.
Published: (2015)

Antitubercular drugs for an old target: GSK693 as a promising InhA direct inhibitor
by: Martínez-Hoyos, María, et al.
Published: (2016)

Aqueous Molecular Dynamics Simulations of the M. tuberculosis Enoyl-ACP Reductase-NADH System and Its Complex with a Substrate Mimic or Diphenyl Ethers Inhibitors
by: da Silva Lima, Camilo Henrique, et al.
Published: (2015)

Interaction Of Isoniazid With Mycobacterium Tuberculosis Enoyl-Acyl Carrier Protein Reductase (INHA) : From Molecular Perspectives [RA644.T7 C548 2008 f rb].
by: Choong, Yee Siew
Published: (2008)

Enzyme Mechanism and Slow-Onset Inhibition of Plasmodium falciparum Enoyl-Acyl Carrier Protein Reductase by an Inorganic Complex
by: de Medeiros, Patrícia Soares de Maria, et al.
Published: (2011)

In house reverse membrane hybridisation assay versus GenoType MTBDRplus and their performance to detect mutations in the genes rpoB, katG and inhA
by: Ferreira, Sergio Luiz Montego, et al.
Published: (2014)

Expression, purification and preliminary crystallographic analysis of the Toxoplasma gondii enoyl reductase
by: Muench, Stephen P., et al.
Published: (2006)

Molecular docking studies on InhA, MabA and PanK enzymes from Mycobacterium tuberculosis of ellagic acid derivatives from Ludwigia adscendens and Trewia nudiflora
by: Shilpi, Jamil A., et al.
Published: (2015)

Correlating drug–target kinetics and in vivo pharmacodynamics: long residence time inhibitors of the FabI enoyl-ACP reductase† †Electronic supplementary information (ESI) available: Derivation of PK/PD models. See DOI: 10.1039/c6sc01000h
by: Daryaee, Fereidoon, et al.
Published: (2016)

Inhibin Alpha-Subunit (INHA) Expression in Adrenocortical Cancer Is Linked to Genetic and Epigenetic INHA Promoter Variation
by: Hofland, Johannes, et al.
Published: (2014)

Role of Serine140 in the mode of action of Mycobacterium tuberculosis β-ketoacyl-ACP Reductase (MabA)
by: Rosado, Leonardo A, et al.
Published: (2012)

Chemical energetics of slow- and fast-twitch muscles of the mouse
Published: (1982)

Expression of INHβA and INHβB proteins in porcine oocytes cultured in vitro is dependent on the follicle size
by: Kempisty, Bartosz, et al.
Published: (2015)

Comparative Modeling and Molecular Dynamics Simulation of Substrate Binding in Human Fatty Acid Synthase: Enoyl Reductase and β-Ketoacyl Reductase Catalytic Domains
by: John, Arun, et al.
Published: (2015)

Experimental study of PLLA/INH slow release implant fabricated by three dimensional printing technique and drug release characteristics in vitro
by: Wu, Gui, et al.
Published: (2014)

The Two Functional Enoyl-Acyl Carrier Protein Reductases of Enterococcus faecalis Do Not Mediate Triclosan Resistance
by: Zhu, Lei, et al.
Published: (2013)

Triclosan Resistome from Metagenome Reveals Diverse Enoyl Acyl Carrier Protein Reductases and Selective Enrichment of Triclosan Resistance Genes
by: Khan, Raees, et al.
Published: (2016)

Functional Characterization of Triclosan-Resistant Enoyl-acyl-carrier Protein Reductase (FabV) in Pseudomonas aeruginosa
by: Huang, Yong-Heng, et al.
Published: (2016)

Computer-Aided Design of Orally Bioavailable Pyrrolidine Carboxamide Inhibitors of Enoyl-Acyl Carrier Protein Reductase of Mycobacterium tuberculosis with Favorable Pharmacokinetic Profiles
by: Kouassi, Affiba Florance, et al.
Published: (2015)

The Interactions of CPP–ACP with Saliva
by: Huq, Noorjahan Laila, et al.
Published: (2016)

3-Oxoacyl-ACP Reductase from Schistosoma japonicum: Integrated In Silico-In Vitro Strategy for Discovering Antischistosomal Lead Compounds
by: Liu, Jian, et al.
Published: (2013)

Discovery of an Allosteric Inhibitor Binding Site in 3-Oxo-acyl-ACP Reductase from Pseudomonas aeruginosa
by: Cukier, Cyprian D., et al.
Published: (2013)

Increasing pinosylvin production in Escherichia coli by reducing the expression level of the gene fabI-encoded enoyl-acyl carrier protein reductase
by: Caheri Salas-Navarrete, et al.
Published: (2018-05-01)

Increasing n-butanol production with Saccharomyces cerevisiae by optimizing acetyl-CoA synthesis, NADH levels and trans-2-enoyl-CoA reductase expression
by: Schadeweg, Virginia, et al.
Published: (2016)

A Novel Cytosolic Isoform of Mitochondrial Trans-2-Enoyl-CoA Reductase Enhances Peroxisome Proliferator-Activated Receptor α Activity
by: Kim, Dong-Gyu, et al.
Published: (2014)